Leadership Overview
Penumbra has 4 executives leading key functions including strategy, finance, information technology, and international operations.
Driven by innovation in medical technology, Penumbra is dedicated to developing groundbreaking devices that improve patient outcomes and address critical unmet needs in neurovascular and other therapeutic areas, solidifying its market leadership through advanced engineering and a commitment to patient care.
Driven by innovation in medical technology, Penumbra is dedicated to developing groundbreaking devices that improve patient outcomes and address critical unmet needs in neurovascular and other therapeutic areas, solidifying its market leadership through advanced engineering and a commitment to patient care.
Leadership Roles at Penumbra
Adam Elsesser - Chief Executive Officer & Chairman of the Board
Adam Elsesser, the Chief Executive Officer & Chairman of the Board at Penumbra, directs the company's overarching strategy and governance. Elsesser guides the development and market introduction of neurovascular access systems and aspiration-based thrombectomy devices, ensuring alignment with Penumbra's mission to improve patient lives. Overseeing all executive functions, the Chief Executive Officer & Chairman of the Board drives innovation across the organization, from product design to global market expansion. This leadership role involves fostering a culture of continuous improvement and strategic growth, essential for Penumbra's position in the medical device industry. By championing new technologies and market opportunities, Adam Elsesser ensures the company remains at the forefront of medical advancements, impacting patient care across the United States, Europe, Canada, Australia, Japan, and other international markets. The executive's focus remains on sustainable growth and delivering value to patients and stakeholders.

Maggie Yuen - Chief Financial Officer
Maggie Yuen, the Chief Financial Officer at Penumbra, manages all financial operations and strategic financial planning. Yuen oversees budgeting, forecasting, and capital allocation to support the company's research, development, and manufacturing of advanced medical devices, including neurovascular access systems and thrombectomy devices. The Chief Financial Officer ensures robust financial controls and compliance across all domestic and international markets where Penumbra operates. This critical role involves optimizing financial performance and securing resources for Penumbra's continued expansion and innovation in areas like the Penumbra System and 3D revascularization devices. By providing key financial insights, Maggie Yuen supports executive decision-making, driving profitability and long-term value creation. The financial leadership ensures the company's fiscal health, enabling sustained investment in product development and market penetration.
James Pray - President, International
James Pray, the President, International at Penumbra, leads the company's strategic initiatives and operational execution across global markets outside the United States. Pray oversees the expansion and management of sales, distribution, and customer support for Penumbra's diverse portfolio of medical devices, including neurovascular access systems and thrombectomy devices, in regions such as Europe, Canada, Australia, and Japan. The President, International drives market penetration and revenue growth by adapting strategies to local healthcare needs and regulatory environments. This executive role is crucial for extending Penumbra's reach and impact on patient care internationally. By fostering strong relationships with international partners and stakeholders, James Pray ensures the successful delivery of innovative medical technologies to a global patient base. The focus remains on expanding market share and enhancing Penumbra's presence worldwide.

Pankaj Tiwari - Executive Vice President & Chief Information Officer
Pankaj Tiwari, the Executive Vice President & Chief Information Officer at Penumbra, directs the company's global information technology strategy and infrastructure. Tiwari oversees the implementation and management of systems that support Penumbra's design, development, manufacturing, and distribution of medical devices, including neurovascular access systems and thrombectomy solutions. The Executive Vice President & Chief Information Officer ensures data security, operational efficiency, and technological innovation across all business functions and geographic regions. This leadership position is vital for integrating advanced digital solutions that enhance product development cycles and streamline global operations. By driving technological advancements, Pankaj Tiwari supports Penumbra's mission to deliver cutting-edge medical devices to patients worldwide. The executive's responsibilities include managing IT resources to foster collaboration and accelerate the company's growth trajectory.

Explore Leadership Teams in Manufacturing
Headquartered in Marlborough, Massachusetts, and formerly part of GE Healthcare Life Sciences, Cytiva is a global provider of medical application technologies and services that advance and accelerate the development of therapeutics.
Company Leadership SO
RM
AL
SE
Nipro Medical Corporation (http://www.nipro.com/), headquartered in Bridgewater, is a wholly-owned subsidiary of Nipro Corporation, headquartered in Osaka, Japan. Established in 1954, our parent company employs more than 29,000 team members and specializes in medical, pharmaceutical, and glass products. Nipro Corporation is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Company Leadership MV
JD
AC
Nipro Corporation, headquartered in Osaka, Japan, has been a provider in medical products to the healthcare community for over 50 years. In addition to Nipro-branded products, Nipro provides manufacturing support to companies in the medical field.
Company Leadership SA
DR
SG
ROMTech® is thrilled to present our patented and groundbreaking rehabilitation technology, designed to serve a variety of orthopedic indications. Our revolutionary technology is improving patient outcomes, cutting cost of care, and overhauling the way postoperative orthopedic care is delivered.
Company Leadership GE

PL
MR